✦ LIBER ✦

The secretion of urokinase-like plasminogen activator is inhibited by microtubule-interacting drugs

✍ Scribed by Juan F. Santibañez; Ricardo B. Maccioni; Jorge Martínez

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 809 KB
Volume: 13
Category: Article
ISSN: 0263-6484
DOI: 10.1002/cbf.290130313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modulation of the receptor for urokinase

Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators

✍ Etsuo Yoshida; Kimiyuki Tsuchiya; Masahiko Sugiki; Hiroyuki Sumi; Hisashi Mihara 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 330 KB

Heparin stimulation of plasminogen activ

Heparin stimulation of plasminogen activator secretion by macrophage-like cell line raw264.7: Role of the scavenger receptor

✍ Domenick J. Falcone 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 925 KB

Secretion of urokinase-type plasminogen activator (uPA) by RAW264.7 cells was stimulated by heparin in a dose-and time-dependent manner. Secretion of uPA was not detected when cells were exposed to heparin at 4"C, indicating that heparin was not simply releasing receptor-bound uPA. Furthermore, prio

TGF-β–induced invasiveness of pancreatic

TGF-β–induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system

✍ Volker Ellenrieder; Sandra F. Hendler; Claudia Ruhland; Wolfgang Boeck; Guido Ad 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB

TGF-beta strongly promotes local tumor progression in advanced epithelial tumors, though the underlying mechanisms are poorly understood. In the present study, we demonstrate the potential of TGF-beta to increase the invasiveness of the pancreatic cancer cell lines PANC-1 and IMIM-PC1. TGF-beta-indu

Inhibition of the invasion capacity of c

Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system

✍ Suna Ertongur; Stephan Lang; Brigitte Mack; Katja Wosikowski; Bernd Muehlenweg; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 803 KB

## Abstract The overall survival rate of patients suffering from carcinomas has remained poor and nearly unchanged over the last decades. This is mainly due to the so‐called minimal residual disease, __i.e__., remaining tumor cells that overcome surgery and/or radiotherapy and are the cause of loco